|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.15 USD | +1.90% |
|
+9.41% | -55.94% |
| 15/05 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
| 14/05 | Top Midday Decliners | MT |
On June 7, 2023, Akoya Biosciences, Inc. announced that Ms. Marilee Moy and Dr. Ehab El-Gabry were terminated as Chief People Officer and Chief Medical Officer, respectively.
| 1st Jan change | Capi. | |
|---|---|---|
| -55.94% | 11Cr | |
| +7.01% | 22TCr | |
| +11.01% | 19TCr | |
| +19.20% | 14TCr | |
| +30.79% | 11TCr | |
| +1.48% | 6.46TCr | |
| +13.95% | 5.24TCr | |
| -0.16% | 4.85TCr | |
| -6.20% | 3.8TCr | |
| +0.91% | 3.56TCr |
AKOYA BIOSCIENCES, INC. 
